HRSA HIV/AIDS Bureau Releases Letter on Sexually Transmitted Infections, Including Mpox
Content From: HIV/AIDS Bureau, Health Resources and Services Administration, U.S. Dept. of Health and Human Services•Published: June 07, 2023•1 min read
Topics
As sexually transmitted infections (STIs), including the recent mpox outbreak, continue to have a disproportionate impact on people with HIV, the Health Resources and Services Administration's (HRSA) HIV/AIDS Bureau’s (HAB) Ryan White HIV/AIDS Program (RWHAP) plays a critical role in addressing STIs for people with HIV. This includes access to treatment for STIs through RWHAP AIDS Drug Assistance Program (ADAP) formularies. On April 26, HRSA HAB released a program letter highlighting the important role RWHAP recipients, including ADAPs, have in addressing STIs and mpox.
Read the new letter.